Skip to main content

Table 11 Changes in lipid measures from day −14 to day 84

From: Effects of dietary supplementation with a standardized aqueous extract of Terminalia chebula fruit (AyuFlex®) on joint mobility, comfort, and functional capacity in healthy overweight subjects: a randomized placebo-controlled clinical trial

Variable

Day −14

Day 84

Within Group p-Value

Between Group p-Value

Cholesterol (mg/dL)

 Placebo

202.2 (±54.0)

192.1 (±47.8)

0.066

0.787

 AF1

198.1 (±59.5)

187.2 (±35.8)

0.153

 AF2

197.0 (±43.3)

190.9 (±39.3)

0.086

 AF1 + AF2

197.5 (±50.9)

189.2 (±37.4)

0.036

 

Triglycerides (mg/dL)

 Placebo

156.0 (±126.7)

143.4 (±101.7)

0.473

0.465

 AF1

112.7 (±60.9)

118.2 (±88.1)

0.626

 AF2

144.4 (±112.1)

129.7 (±80.0)

0.153

 AF1 + AF2

129.9 (±92.9)

124.4 (±83.3)

0.470

 

HDL (mg/dL)

 Placebo

55.1 (±17.4)

53.3 (±15.9)

0.209

0.294

 AF1

56.5 (±18.9)

55.5 (±19.3)

0.258

 AF2

52.2 (±16.1)

52.8 (±15.7)

0.577

 AF1 + AF2

54.2 (±17.4)

54.0 (±17.3)

0.853

 

LDL (mg/dL)

 Placebo

115.1 (±37.4)

110.1 (±38.1)

0.217

0.550

 AF1

119.1 (±54.9)

108.0 (±33.4)

0.154

 AF2

119.7 (±32.8)

116.1 (±29.0)

0.254

 AF1 + AF2

119.4 (±43.9)

112.4 (±31.1)

0.072

 
  1. Values Presented as Mean ± Standard Deviation
  2. Values determined to be significant (p = <0.05) indicated